Ben Tre Pharmaceutical JSC (STC:DBT) Interest Coverage: 0 (At Loss) (As of . 20)


STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
13 GF Score
Price ₫12,000.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC Interest Coverage?

Ben Tre Pharmaceutical JSC STC:DBT -6.25% 13 Interest Coverage is 0 (At Loss) as of . 20. GuruFocus rates STC:DBT with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 684 Drug Manufacturers companies, Ben Tre Pharmaceutical JSC ranks worse than 146198.68% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Ben Tre Pharmaceutical JSC's Operating Income for the six months ended in . 20 was ₫0.00 Mil. Ben Tre Pharmaceutical JSC's Interest Expense for the six months ended in . 20 was ₫0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's Interest Coverage or its related term are showing as below:


STC:DBT's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.765
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Ben Tre Pharmaceutical JSC  (STC:DBT) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Ben Tre Pharmaceutical JSC Interest Coverage Related Terms


Ben Tre Pharmaceutical JSC Interest Coverage Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Ben Tre Pharmaceutical JSC Interest Coverage Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
Interest Coverage

Ben Tre Pharmaceutical JSC Semi-Annual Data
Interest Coverage

STC:DBT vs ZTS, UTHR, VTRS: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ben Tre Pharmaceutical JSC Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's Interest Coverage falls into.


STC:DBT
13GF Score
Ben Tre Pharmaceutical JSC STC:DBT
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ben Tre Pharmaceutical JSC's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Ben Tre Pharmaceutical JSC's Interest Expense was ₫0.00 Mil. Its Operating Income was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was ₫0.00 Mil.

Ben Tre Pharmaceutical JSC had no debt (1).

Ben Tre Pharmaceutical JSC's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the six months ended in . 20, Ben Tre Pharmaceutical JSC's Interest Expense was ₫0.00 Mil. Its Operating Income was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was ₫0.00 Mil.

Ben Tre Pharmaceutical JSC had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a Interest Coverage of 0 (At Loss) as of . 20. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ben Tre Pharmaceutical JSC and its competitors. According to the industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 684 companies in the Drug Manufacturers industry.
Is Ben Tre Pharmaceutical JSC's Interest Coverage too high?
Ben Tre Pharmaceutical JSC's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 684 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 684 companies for Interest Coverage. This places Ben Tre Pharmaceutical JSC in the lower half of its industry. The industry median Interest Coverage is 12.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ben Tre Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ben Tre Pharmaceutical JSC's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Ben Tre Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current Interest Coverage is 0 (At Loss) as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
13GF Score

Get the complete analysis for STC:DBT

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫12,000.00
Price